The Effect Duration of Candesartan Cilexetil Once Daily, in Comparison with Enalapril Once Daily, in Patients with Mild to Moderate Hypertension

By Himmelmänn Anders   Keinanen-Kiukaanniemi Sirkka   Wester Anno   Redón Josep   Asmar Roland   Hedner Thomas  

Blood Pressure, Vol. 10, Iss. 1, 2001-02 ,pp. : 43-51

Informa Healthcare

Access to resources Recommend Favorite

A Combination of Candesartan Cilexetil/hydrochlorothiazide (HCTZ), 8/12.5 mg, has a Similar Antihypertensive Efficacy and is Better Tolerated than Lisinopril/HCTZ, 10/12.5 mg

By McINNES G. T.   ISTAD H.   KEINÄNEN-KIUKAANNIEMI S.   VAN MIERLO H. F. C. M.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 61-61

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive Treatment with Candesartan Cilexetil does not Affect Glucose Homeostasis or Serum Lipid Profile in Patients with Mild Hypertension and Type II Diabetes

By TRENKWALDER PETER   DAHL KETIL   LEHTOVIRTA MIKKO   MULDER HENK  

Blood Pressure, Vol. 7, Iss. 3, 1998-08 ,pp. : 170-175

Informa Healthcare

Access to resources Recommend Favorite

The Antihypertensive Effect and Tolerability of Candesartan Cilexetil, a New Generation Angiotensin II Antagonist, in Comparison with Losartan

By ANDERSSON OVE K.   NELDAM STEEN  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability

By ELMFELDT D.   GEORGE M.   HÜBNER R.   OLOFSSON B.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 54-54

Informa Healthcare

Access to resources Recommend Favorite